Panmure Liberum appointed as Joint Broker to AOTI Inc.

AOTI, Inc. is a US based medical technology group which engages in the design, manufacture, and provision of topical oxygen therapy products and services. The company serves healthcare providers and patients, with a particular emphasis on limb preservation and the prevention of amputations. Its products include the Topical Wound Oxygen Therapy and the NEXA Negative Pressure Wound Therapy System which are supported by strong clinical evidence and health economic data.

The Group operates within the global advanced wound care market, valued at over $14 billion, which is primarily driven by the rising prevalence of chronic diseases like Type 2 diabetes and the increasing lifespan of patients with chronic co-morbidities.

Panmure Liberum Team

Investment Banking – Emma Earl, Will Goode, Mark Rogers, Izzy Anderson

Corporate Broking – Rupert Dearden

Research – Julie Simmonds

Sales – David Cox, Anita Surana

IR – Jodi Hutchins​